Submit Content
Get the latest delivered to your inbox
Privacy Policy

The Road to a Vaccine, Ep. 4: What Doctors on the Front Lines of COVID-19 Are Now Saying About the Virus

Published 05-06-20

Submitted by Johnson & Johnson

Click here for video

This new eight-episode educational video series will examine the latest efforts to respond to the COVID-19 pandemic and break down the complex process of developing a vaccine.

Each week our host Lisa Ling will talk to leading scientists and researchers, healthcare workers on the front lines and public health experts around the world working collaboratively to help bring an end to the deadly pandemic.

This week in Episode 4, host Lisa Ling speaks with Dr. Adaora Okoli, an internal resident physician at the Tulane University School of Medicine, about how she contracted Ebola in Nigeria—and recovered—and how she stays positive while treating COVID-19 patients in New Orleans. Renowned epidemiologist Dr. Larry Brilliant discusses what it was like to help eradicate smallpox, and why testing is so important during the current crisis.

Also, vaccine scientist Dr. Johan Van Hoof helps us separate fact from fiction around the question: How long could the immunity provided by a potential vaccine last? Finally, Dr. Ed Kuffner, Chief Medical Officer, Johnson & Johnson Family of Consumer Companies, and Dr. Caleb Hernandez, a board certified emergency medicine physician and founder of Certa Dose, talk about volunteering in the COVID-19 trenches at a Brooklyn hospital.

Tune in live at 12 pm EDT Tuesdays on JNJ.comFacebookLinkedIn or Twitter. Come back to this page at any time to watch a replay.

Johnson & Johnson Logo

Johnson & Johnson

Johnson & Johnson

Caring for the world, one person at a time... inspires and unites the people of Johnson & Johnson. This year, we celebrate 126 years of embracing research and science – bringing innovative ideas, products and services to advance the health and well-being of people. Employees of the Johnson & Johnson Family of Companies work in more than 250 operating companies in 60 countries throughout the world. The passion and commitment of our people yield innovations that further minimize our impact on the planet, drive new alliances to address major health challenges in developing and developed countries, and help to create economic opportunity for people. Improving human health and well-being is our crucial mission and the ultimate measure of upholding our responsibility now and for generations to come.

At Johnson & Johnson, our top priority is health-health of people and the planet. That's why we set aggressive corporate wide goals to reduce our environmental impact, outlined in our Healthy Future 2015 goals. To this end, we established the proprietary Earthwards® process for developing and marketing greener products through lifecycle analysis. Every Earthwards® recognized product must achieve a greater than 10 percent improvement in at least three of the seven goal areas:

  • Materials used
  • Packaging reduction
  • Energy reduction
  • Waste reduction
  • Water reduction
  • Positive social impact or benefit
  • Product innovation

More from Johnson & Johnson

Join today and get the latest delivered to your inbox